Global Iodine-125 (I-125) Sealed Seed Source Market Growth (Status and Outlook) 2024-2030

Global Iodine-125 (I-125) Sealed Seed Source Market Growth (Status and Outlook) 2024-2030

The I-125 Seed Source is a pre-sterilized 18G stainless steel needle containing low activity I-125 iodine seed. The I-125 source consists of a laser-welded titanium capsule containing iodine-125 adsorbed on a silver rod that acts as an x-ray detectable marker.

The global Iodine-125 (I-125) Sealed Seed Source market size is projected to grow from US$ 101 million in 2024 to US$ 206 million in 2030; it is expected to grow at a CAGR of 12.6% from 2024 to 2030.

LPI (LP Information)' newest research report, the “Iodine-125 (I-125) Sealed Seed Source Industry Forecast” looks at past sales and reviews total world Iodine-125 (I-125) Sealed Seed Source sales in 2022, providing a comprehensive analysis by region and market sector of projected Iodine-125 (I-125) Sealed Seed Source sales for 2023 through 2029. With Iodine-125 (I-125) Sealed Seed Source sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Iodine-125 (I-125) Sealed Seed Source industry.

This Insight Report provides a comprehensive analysis of the global Iodine-125 (I-125) Sealed Seed Source landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Iodine-125 (I-125) Sealed Seed Source portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Iodine-125 (I-125) Sealed Seed Source market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Iodine-125 (I-125) Sealed Seed Source and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Iodine-125 (I-125) Sealed Seed Source.

United States market for Iodine-125 (I-125) Sealed Seed Source is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Iodine-125 (I-125) Sealed Seed Source is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Iodine-125 (I-125) Sealed Seed Source is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Iodine-125 (I-125) Sealed Seed Source players cover NRG, China Isotope & Radiation Corporation (CIRC), Dongcheng Pharmaceutical, BD, Eckert & Ziegler, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Iodine-125 (I-125) Sealed Seed Source market by product type, application, key players and key regions and countries.

Segmentation by Type:
< 10 MBq
≥ 10 MBq

Segmentation by Application:
Breast Tumor Localization
Prostate Cancer Treatment

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

Segmentation by Type:
< 10 MBq
≥ 10 MBq

Segmentation by Application:
Breast Tumor Localization
Prostate Cancer Treatment

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
NRG
China Isotope & Radiation Corporation (CIRC)
Dongcheng Pharmaceutical
BD
Eckert & Ziegler
BXTAccelyon
Chengdu Yunke
Zhibo Bio-Medical
Seeds Biological Pharmacy (Tianjin) Ltd.
SHENZHEN LEW Bioengineering Technolohy

Please note: The report will take approximately 2 business days to prepare and deliver.